International Patent: RETINAL PROGENITOR CELLS HAVING ABILITY TO DIFFERENTIATE INTO RETINAL PIGMENT EPITHELIAL CELLS, PHOTORECEPTOR CELLS, AND CRYSTALLINE LENS EPITHELIAL CELLS, AND MASS PRODUCTION METHOD THEREFOR

GENEVA, Aug. 31 -- SUNGKWANG MEDICAL FOUNDATION filed a patent application (KR2025/017144) for “RETINAL PROGENITOR CELLS HAVING ABILITY TO DIFFERENTIATE INTO RETINAL PIGMENT EPITHELIAL CELLS, PHOTORECEPTOR CELLS, AND CRYSTALLINE LENS EPITHELIAL CELLS, AND MASS PRODUCTION METHOD THEREFOR”. With publication no. WO/2026/177304, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12N 5/079

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....